8 Amsterdam healthtech investors back biotech and digital health startups in 2026. LSP and Forbion are Europe's leading dedicated life sciences VCs. Gilde Healthcare backs digital health at growth stage. HealthInc connects founders to Amsterdam's AMC and VU hospital networks.
Amsterdam's life sciences cluster ranks among Europe's top three alongside London and Munich. AMC, VU Medical Centre, and Antoni van Leeuwenhoek Cancer Institute anchor the Amsterdam healthtech network.
Netherlands Clinical Research Foundation processed 800+ clinical trials in 2025. Amsterdam healthtech founders access clinical validation 40% faster than German equivalents.
Dutch Health and Youth Care Inspectorate is Europe's most predictable medical device regulator. MDR and IVDR approvals from Amsterdam typically run 6 months faster than UK MHRA timelines.
This guide covers 8 active healthtech investors in Amsterdam writing cheques in 2026.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| LSP (Life Sciences Partners) | Dedicated life sciences VC | $5M-$50M | Biotech, medtech, digital health | lspvc.com |
| Forbion | Dedicated biotech VC | $5M-$40M | Biotech, medtech, therapeutics | forbion.com |
| Gilde Healthcare | Dedicated healthcare VC | $2M-$30M | Digital health, medtech, pharma | gildehealthcare.com |
| Inkef Capital | Deep tech VC | $1M-$10M | Healthtech, digital health, life sciences | inkef.com |
| BioGeneration Ventures | Early-stage biotech VC | $1M-$8M | Biotech, therapeutics, drug discovery | biogenerationventures.com |
| HealthInc | Healthtech accelerator | $100K-$500K | Digital health, medtech, AI diagnostics | healthinc.nl |
| Antler Amsterdam | Pre-seed program | $100K-$500K | Digital health, AI diagnostics, health SaaS | antler.co |
| Peak Capital | Seed to Series A | $500K-$5M | Digital health SaaS, health consumer tech | peakcapital.com |
Track your Amsterdam healthtech investor pipeline
Ellty shows who opened your pitch and how long they spent reviewing your clinical data. Follow up at the right time.
Start free 14-day trialWhat Amsterdam healthtech VCs look for
LSP and Forbion require clinical evidence and peer-reviewed data before any term sheet. Digital health VCs like Gilde move faster but still demand NHS or Dutch hospital validation.
MDR-compliant software architecture is table stakes for Amsterdam medical device funding. Founders with CE marking timeline and QMDS documentation close Amsterdam rounds 4 months faster.
Organise your clinical trial data and regulatory docs in a startup data room that tracks which VCs reviewed your clinical evidence and MDR sections. Amsterdam healthtech VCs share decks within their networks - know who forwarded yours first.
Reimbursement pathway from Dutch Zorgverzekeraars (insurance) is the key commercial question. Healthtech founders with NZa reimbursement or ZN pilot letters close Amsterdam VC rounds fastest.
Amsterdam healthtech founders who close fastest have a Dutch hospital validation letter and a clear NZa reimbursement pathway. Clinical data is the only currency that converts here.
8 Amsterdam healthtech investors
1. LSP - Life Sciences Partners
Europe's largest life sciences fund with Dutch MDR and health insurance network.
Recent Deals: Life sciences investments 2025-2026; Dutch MDR regulatory network; European pharma and medtech portfolio
LinkedIn: LSP - Life Sciences Partners LinkedIn
Sector Focus: Healthtech, life sciences, medtech
Stage Focus: Seed to growth
Location: Amsterdam, Netherlands
Website: lspvc.com
2. Forbion
Netherlands biotech and healthtech specialist with deepest Dutch clinical trial network.
Recent Deals: Biotech and healthtech investments 2025; Dutch clinical trial network; EMA regulatory expertise active
LinkedIn: Forbion LinkedIn
Sector Focus: Healthtech, biotech, clinical
Stage Focus: Seed, Series A
Location: Naarden, Netherlands
Website: forbion.com
3. Gilde Healthcare
Dutch healthtech specialist with health insurance reimbursement and hospital network.
Recent Deals: Healthtech investments 2025; Dutch health insurance connections; hospital and payer network active
LinkedIn: Gilde Healthcare LinkedIn
Sector Focus: Healthtech, digital health
Stage Focus: Seed, Series A
Location: Utrecht, Netherlands
Website: gildehealthcare.com
4. Inkef Capital
ABN AMRO-linked healthtech fund with Dutch hospital and corporate health network.
Recent Deals: Healthtech investments 2025; ABN AMRO corporate health connections; Dutch hospital network active
LinkedIn: Inkef Capital LinkedIn
Sector Focus: Healthtech, digital health
Stage Focus: Seed, Series A
Location: Amsterdam, Netherlands
Website: inkef.com
5. BioGeneration Ventures
Dutch biotech seed specialist with TU Delft and Wageningen university network.
Recent Deals: Biotech seed investments 2025; TU Delft and Wageningen connections; Dutch university spin-out pipeline
LinkedIn: BioGeneration Ventures LinkedIn
Sector Focus: Biotech, life sciences
Stage Focus: Seed
Location: Leiden, Netherlands
Website: biogenerationventures.com
6. HealthInc
Amsterdam's dedicated healthtech accelerator with Philips and hospital corporate network.
Recent Deals: Healthtech accelerator investments 2025; Philips and hospital corporate network; Dutch health market
LinkedIn: HealthInc LinkedIn
Sector Focus: Healthtech, digital health
Stage Focus: Pre-seed, seed
Location: Amsterdam, Netherlands
Website: healthinc.nl
Track who's reading your Amsterdam healthtech pitch
Ellty shows you which healthtech VCs opened your deck and how long they spent on it.
Start free 14-day trial7. Antler Amsterdam
Pre-company healthtech investor backing founding teams before product exists.
Recent Deals: Pre-company healthtech 2025-2026; Amsterdam cohort; technical co-founder matching active
LinkedIn: Antler Amsterdam LinkedIn
Sector Focus: Healthtech, pre-seed
Stage Focus: Pre-idea, pre-seed
Location: Amsterdam, Netherlands
Website: antler.co
8. Peak Capital
Amsterdam's top early-stage fund with digital health and B2B SaaS healthtech mandate.
Recent Deals: Digital health and B2B investments 2025-2026; Benelux corporate network; health SaaS portfolio active
LinkedIn: Peak Capital LinkedIn
Sector Focus: Healthtech, B2B SaaS
Stage Focus: Seed, Series A
Location: Amsterdam, Netherlands
Website: peak.capital
MDR and Dutch health regulation
EU Medical Device Regulation (MDR 2017/745) applies to all software as medical devices in Amsterdam. Class IIa and above software requires Notified Body conformity assessment before commercial launch.
Dutch IGJ (Health and Youth Care Inspectorate) is Amsterdam's medical device supervisor. IGJ post-market surveillance inspections are predictable - compliance calendars exist for all device classes.
Track your MDR certification timeline and investor conversations with secure file sharing tools that manage regulatory and fundraising pipelines. Amsterdam healthtech VCs check IGJ registration status as the first compliance question.
GDPR Article 9 applies to all health data processed in Amsterdam - special category protection applies. Healthtech founders must implement pseudonymization and data minimization before any Dutch hospital pilot.
Dutch health insurance reimbursement
Netherlands has universal health insurance (Zvw) covering 17.9M citizens through private insurers. NZa (Dutch Healthcare Authority) sets reimbursement rates for all covered treatments and digital health tools.
ZN (Association of Health Insurers) pilot letters are the fastest path to Dutch market validation. A Zilveren Kruis or VGZ pilot letter converts Amsterdam healthtech VCs in weeks.
Keep your reimbursement documentation organized with an investor portal that tracks NZa applications and VC engagement simultaneously. Amsterdam healthtech VCs share deals - know who forwarded your deck before your follow-up.
Direct health insurance billing via Vektis requires AGB code registration. AGB code registration takes 4-6 weeks and is required before any Dutch health insurer billing.
Amsterdam vs German healthtech fundraising
Amsterdam healthtech rounds close 30% faster than Munich equivalents at seed stage. Dutch clinical trial timelines are shorter and MDR costs are lower than German equivalents.
German healthtech requires DiGA (Digital Health Application) certification for reimbursement. Dutch NZa pilot process is 6 months faster than German DiGA certification from day one.
Review our due diligence process guide before your first Amsterdam healthtech VC meeting. Dutch VCs ask harder clinical evidence questions but move faster than German counterparts.
Amsterdam-Munich dual HQ at Series B is common for European healthtech scale-ups. Raise Amsterdam Series A, then add a Munich Burda or HV Capital co-investor for German market.
Venture Capital in 2026: AI, Liquidity & Startup Funding Explained
How to pitch an Amsterdam healthtech investor
Lead with Dutch hospital validation and MDR compliance status. Clinical evidence first.
- 1.Get an AMC or VU Medical Centre pilot letterHospital validation converts Amsterdam VCs fastest.
- 2.Map your MDR class and Notified Body timelineClass and CE timeline is the first regulatory question.
- 3.Show NZa reimbursement pathway with insurer contactReimbursement pathway is the key commercial gate.
- 4.Send deck via Ellty and track who reviews your clinical dataFollow up when VCs view your clinical evidence section.
- 5.Follow up once after 10 business daysHealthtech VCs take longer. One clear follow-up works.
How Ellty helps you land an Amsterdam healthtech investor
Ellty is a data room for healthtech founders. Track VC interest in your clinical documents.
- 1.Organise your healthtech fundraising documentsAdd deck, MDR docs, and clinical data. Set access.
- 2.Share trackable links with Amsterdam healthtech VCsSend each VC a unique link. Ellty logs every open.
- 3.Follow up when VCs review your clinical sectionSee which VCs opened your clinical evidence today.
Amsterdam healthtech investors: common questions
- Seed cheques run €1M-€5M. HealthInc and Antler write the fastest pre-seed decisions.
- Not at pre-seed. MDR plan and Notified Body selection is required before Series A.
- Seed closes in 8-12 weeks. Life sciences VCs like LSP take 12-20 weeks.
- AI diagnostics, digital therapeutics, and hospital workflow automation lead mandates.
- Yes, but Dutch BV speeds NZa applications and hospital partnership agreements significantly.
